» Articles » PMID: 37175796

Neonatal Cardiovascular-Progenitor-Cell-Derived Extracellular Vesicles Activate YAP1 in Adult Cardiac Progenitor Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 May 13
PMID 37175796
Authors
Affiliations
Soon will be listed here.
Abstract

New stem cell and extracellular-vesicle-based therapies have the potential to improve outcomes for the increasing number of patients with heart failure. Since neonates have a significantly enhanced regenerative ability, we hypothesized that extracellular vesicles isolated from Islet-1+ expressing neonatal human cardiovascular progenitors (CPCs) will induce transcriptomic changes associated with improved regenerative capability when co-cultured with CPCs derived from adult humans. In order to test this hypothesis, we isolated extracellular vesicles from human neonatal Islet-1+ CPCs, analyzed the extracellular vesicle content using RNAseq, and treated adult CPCs with extracellular vesicles derived from neonatal CPCs to assess their functional effect. AKT, ERBB, and YAP1 transcripts were elevated in adult CPCs treated with neonatal CPC-derived extracellular vesicles. YAP1 is lost after the neonatal period but can stimulate cardiac regeneration. Our results demonstrate that YAP1 and additional transcripts associated with improved cardiovascular regeneration, as well as the activation of the cell cycle, can be achieved by the treatment of adult CPCs with neonatal CPC-derived extracellular vesicles. Progenitor cells derived from neonates secrete extracellular vesicles with the potential to stimulate and potentially improve functional effects in adult CPCs used for cardiovascular repair.

Citing Articles

Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.

Fiorino E, Rossin D, Vanni R, Aubry M, Giachino C, Rastaldo R Int J Mol Sci. 2024; 25(21).

PMID: 39519298 PMC: 11546116. DOI: 10.3390/ijms252111747.

References
1.
Xin M, Kim Y, Sutherland L, Murakami M, Qi X, McAnally J . Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A. 2013; 110(34):13839-44. PMC: 3752208. DOI: 10.1073/pnas.1313192110. View

2.
Zhu Y, Do V, Richards A, Foo R . What we know about cardiomyocyte dedifferentiation. J Mol Cell Cardiol. 2020; 152:80-91. DOI: 10.1016/j.yjmcc.2020.11.016. View

3.
Li Y, Tian S, Lei I, Liu L, Ma P, Wang Z . Transplantation of multipotent Isl1+ cardiac progenitor cells preserves infarcted heart function in mice. Am J Transl Res. 2017; 9(3):1530-1542. PMC: 5376043. View

4.
Kang K, Ma R, Cai W, Huang W, Paul C, Liang J . Exosomes Secreted from CXCR4 Overexpressing Mesenchymal Stem Cells Promote Cardioprotection via Akt Signaling Pathway following Myocardial Infarction. Stem Cells Int. 2015; 2015:659890. PMC: 4436515. DOI: 10.1155/2015/659890. View

5.
Hubert F, Payan S, Pelce E, Bouchard L, Sturny R, Lenfant N . FGF10 promotes cardiac repair through a dual cellular mechanism increasing cardiomyocyte renewal and inhibiting fibrosis. Cardiovasc Res. 2021; 118(12):2625-2637. DOI: 10.1093/cvr/cvab340. View